ICON plc/$ICLR
1D1W1MYTD1Y5YMAX
About ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
- Ticker
- $ICLR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 40,200
- Headquarters
- Dublin, Ireland
- Website
- www.iconplc.com
ICON plc Metrics
BasicAdvanced
$13B
472.44
$0.35
1.20
-
Price and volume
Market cap
$13B
Beta
1.2
52-week high
$203.91
52-week low
$66.57
Average daily volume
726K
Financial strength
Current ratio
0.953
Quick ratio
0.924
Long term debt to equity
23.603
Total debt to equity
37.596
Interest coverage (TTM)
1.32%
Profitability
EBITDA (TTM)
523.481
Gross margin (TTM)
23.91%
Net profit margin (TTM)
0.33%
Operating margin (TTM)
3.09%
Effective tax rate (TTM)
68.65%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
0.97%
Return on equity (TTM)
0.29%
Valuation
Price to earnings (TTM)
472.439
Price to revenue (TTM)
1.528
Price to book
1.36
Price to tangible book (TTM)
-5.11
Price to free cash flow (TTM)
13.692
Free cash flow yield (TTM)
7.30%
Free cash flow per share (TTM)
12.05
Growth
Revenue change (TTM)
3.26%
Earnings per share change (TTM)
-96.23%
3-year revenue growth (CAGR)
1.62%
10-year revenue growth (CAGR)
17.82%
3-year earnings per share growth (CAGR)
-61.62%
10-year earnings per share growth (CAGR)
-22.25%
What the Analysts think about ICON plc
Analyst ratings (Buy, Hold, Sell) for ICON plc stock.
ICON plc Financial Performance
Revenues and expenses
ICON plc Earnings Performance
Company profitability
ICON plc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.